EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Addition of Amitriptyline or Placebo to Speech Pathology for Inducible Laryngeal Obstruction: A Double-Blind Randomized Controlled Trial

Janine Mahoney, Mark Hew, Anne Vertigan, Joy Lee, Eve Denton, Jennifer Oates

The Journal of Allergy and Clinical Immunology: In Practice · 2026-06 · 14 (6) · 1430-1437.e1

DOI: 10.1016/j.jaip.2026.02.019 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-06. Verfasst von Janine Mahoney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Speech Pathology, La Trobe University, Melbourne, Victoria, Australia; Speech Pathology Department, The Alfred, Melbourne, Victoria, Au…. Hauptthemen laut MEDLINE: Amitriptyline, Speech Therapy, Airway Obstruction, Laryngeal Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmitriptylineSpeech TherapyAirway ObstructionLaryngeal DiseasesHumansDouble-Blind MethodMiddle AgedFemaleAdultMaleAgedYoung AdultAged, 80 and overAdolescentTreatment OutcomeCombined Modality Therapy

Stichwörter der Autor:innen

AmitriptylineInducible laryngeal obstructionSpeech pathologyTreatment

Substanzen

Amitriptyline

Autor:innen und Institutionen

  • Department of Speech Pathology, La Trobe University, Melbourne, Victoria, Australia; Speech Pathology Department, The Alfred, Melbourne, Victoria, Australia. Electronic address: J.Mahoney@alfred.org.au.
  • Allergy, Asthma, and Clinical Immunology Service, The Alfred, Melbourne, Victoria, Australia; Department of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Department of Speech Pathology, John Hunter Hospital, Newcastle, New South Wales, Australia; College of Health, Medicine and Wellbeing, School of Medicine and Public Health, University of Newcastle, Newcastle, New South…
  • Allergy, Asthma, and Clinical Immunology Service, The Alfred, Melbourne, Victoria, Australia; The Department of Respiratory Research @ Alfred, School of Translational Medicine, Monash University, Melbourne, Victoria, Au…
  • Department of Speech Pathology, La Trobe University, Melbourne, Victoria, Australia.

Zitieren

APA

Mahoney, J., Hew, M., Vertigan, A., Lee, J., Denton, E., & Oates, J. (2026). Addition of Amitriptyline or Placebo to Speech Pathology for Inducible Laryngeal Obstruction: A Double-Blind Randomized Controlled Trial. The Journal of Allergy and Clinical Immunology: In Practice, 14(6), 1430-1437.e1. https://doi.org/10.1016/j.jaip.2026.02.019

Vancouver

Mahoney J, Hew M, Vertigan A, Lee J, Denton E, Oates J. Addition of Amitriptyline or Placebo to Speech Pathology for Inducible Laryngeal Obstruction: A Double-Blind Randomized Controlled Trial. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(6):1430-1437.e1. doi:10.1016/j.jaip.2026.02.019

BibTeX
@article{Mahoney2026,
  author = {Mahoney, Janine and Hew, Mark and Vertigan, Anne and Lee, Joy and Denton, Eve and Oates, Jennifer},
  title = {Addition of Amitriptyline or Placebo to Speech Pathology for Inducible Laryngeal Obstruction: A Double-Blind Randomized Controlled Trial},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  volume = {14},
  number = {6},
  pages = {1430--1437.e1},
  doi = {10.1016/j.jaip.2026.02.019}
}
Kostenlos starten →